BoneSupport, specialists in injectable bioceramic bone scaffolds to treat voids, has appointed of Michael Diefenbeck as Chief Medical Officer.
Diefenbeck founded Scientific Consulting in Orthopaedic Surgery in 2014 and has worked for BoneSupport on a range of clinical projects related to Cerament as an independent clinical advisor.
He is currently honorary consultant at Nuffield Orthopaedic Centre, Oxford University Hospitals. Diefenbeck studied medicine at Munich and was trained as an orthopaedic surgeon, specialising in trauma care and bone infections.
He has 14 years’ clinical experience at different German hospitals. At University Hospital Jena, he finished his PhD in 2011 and has since been involved in surgical education and training programmes for students. He is author of 24 Pub-med listed research articles.
Richard Davies, CEO of BoneSupport, said: “I have no doubt that Michael's extensive medical experience in the orthopaedics field will be a real asset to BoneSupport.”
